A gestational surrogate does not pass on her nuclear DNA to the baby she carries. The child’s genetic blueprint comes entirely from the egg provider and the sperm provider. But the relationship between a surrogate and the developing fetus turns out to be more biologically intimate than a simple “oven” metaphor suggests. Research over the past two decades has revealed that the pregnant body influences the embryo through cell exchange, molecular signaling, and chemical modifications that can shape how the child’s genes behave, even without altering the genes themselves.
Gestational Versus Traditional Surrogacy
The answer to whether a surrogate passes on DNA depends entirely on which type of surrogacy is involved. In gestational surrogacy, an embryo created from someone else’s egg and sperm is transferred into the surrogate’s uterus. The surrogate provides the womb but contributes no egg, so her chromosomes are not part of the child’s genome. This is the most common form of surrogacy practiced today in fertility clinics worldwide.
In traditional surrogacy, the surrogate uses her own egg, which is fertilized with the intended father’s sperm (or donor sperm). Because she contributes the egg, a traditional surrogate is the biological and genetic mother of the child, supplying half of its nuclear DNA plus all of its mitochondrial DNA. The distinction is absolute at the level of the genome: gestational surrogates contribute zero chromosomal DNA, while traditional surrogates contribute exactly as much as any biological mother would.
For the rest of this article, when we say “surrogate,” we mean a gestational surrogate, since that is the arrangement most people are asking about when they wonder whether a surrogate’s DNA ends up in the baby.
Microchimerism and the Cells That Cross the Placenta
Even though a gestational surrogate does not contribute her chromosomes to the embryo, a small number of her cells do cross into the fetus during pregnancy, and fetal cells cross back into her. This two-way traffic through the placenta is called microchimerism, and it happens in every pregnancy, not just surrogate ones. The cells are few in number, but they can survive in the recipient’s body for years or even decades.
Research using placental perfusion models has confirmed that this bidirectional exchange allows genetically foreign cells to persist long-term in both the mother and child.1Placenta. Addressing microchimerism in pregnancy by ex vivo human placenta perfusion In the context of gestational surrogacy, this means a small population of the surrogate’s cells may remain in the child’s body after birth, and a small population of fetal cells may remain in the surrogate. These cells carry the surrogate’s full genome, so technically, fragments of her DNA do reside in the child’s tissues. But this is a far cry from contributing to the child’s genetic identity. Microchimeric cells are scattered stragglers, not architects of the child’s genome. The child’s own cells, with DNA from the egg and sperm providers, vastly outnumber them.
That said, microchimeric cells are not biologically inert. Studies have found that maternal microchimeric cells, primarily T lymphocytes, can influence the development of the offspring’s immune system. These maternal cells have been observed in the thymus, where offspring T cells mature, and in lymph nodes, where B cells develop. There is even evidence that they help transfer immune memory across generations, and that they can partially compensate for immunodeficiencies in the offspring.2PubMed Central. Maternal-Fetal Microchimerism: Impacts on Offspring’s Immune Development and Transgenerational Immune Memory Transfer Whether these effects are meaningful in gestational surrogacy specifically, where the surrogate is genetically unrelated to the fetus, is still being studied. But the cells are there.
How the Surrogate’s Body Shapes Gene Expression
The more consequential way a gestational surrogate influences the baby has nothing to do with contributing DNA and everything to do with affecting how the baby’s existing DNA is read. This falls under the umbrella of epigenetics: chemical modifications that sit on top of the DNA sequence and act like volume knobs, turning genes up or down without changing the underlying code.
These epigenetic processes are highly active throughout pregnancy and respond to both maternal-fetal signals and environmental conditions. Research has established that they play a pivotal role from the earliest stages of embryo implantation all the way through fetal development, with effects that can persist into adult life.3PubMed Central. Epigenetics of pregnancy: looking beyond the DNA code The surrogate’s nutrition, stress levels, hormone environment, sleep patterns, exposure to pollutants, and general health all feed into this system. A fetus developing in two different uteruses with the same DNA could, in principle, end up with different patterns of gene expression depending on the conditions each pregnancy provided.
This is not a hypothetical concern. The concept is well established through the Developmental Origins of Health and Disease framework, which explains how conditions in the womb can alter fetal programming and increase or decrease susceptibility to metabolic disorders later in life.4PubMed Central. The Hidden Impact of Gestational Diabetes: Unveiling Offspring Complications and Long-Term Effects A surrogate with gestational diabetes, for instance, exposes the fetus to elevated blood sugar that can shift the epigenetic settings on genes related to metabolism. The child’s DNA sequence is unchanged, but its metabolic trajectory may be different than it would have been in a different uterine environment.
So when people ask “does the surrogate pass on DNA,” the more precise question might be: does the surrogate influence which parts of the baby’s DNA are active and how strongly? The answer to that is clearly yes.
Extracellular Vesicles and the Molecular Conversation
One of the most striking discoveries in reproductive biology over the past decade is that the uterine lining actively sends molecular packages to the embryo. These tiny membrane-bound parcels, called extracellular vesicles, are released by the endometrium and taken up by the developing embryo. They carry microRNAs and proteins that can directly influence gene activity in the embryo’s cells.
Studies have shown that extracellular vesicles from the endometrium, oviduct, and decidua interact with trophoblast cells and promote their growth and differentiation, aiding in embryo implantation.5PubMed Central. Extracellular vesicle mediated embryo-endometrial cross talk during implantation and in pregnancy This is not a passive process. The uterine lining is essentially sending instructions to the embryo about how to implant, how fast to grow, and how to differentiate its early cell types.
The content of these vesicles has been cataloged in some detail. One study identified 149 annotated microRNAs in endometrial extracellular vesicles taken up by human blastocysts, with 37 deemed highly relevant. Those microRNAs collectively targeted thousands of genes involved in embryo development, cell differentiation, oxygen metabolism, cell cycling, and gene expression regulation.6Human Reproduction. Human blastocysts uptake extracellular vesicles secreted by endometrial cells containing miRNAs related to implantation Among the key regulators identified were members of the let-7 family and miR-21, both of which are known to influence fundamental cellular processes.
Research in mice has taken this further, demonstrating that let-7 microRNAs from endometrial vesicles can suppress specific signaling pathways in embryos, even inducing a state of suspended development called embryonic diapause. When tested on human embryo models, the same microRNA family blocked trophoblast differentiation and prolonged blastocyst survival in lab conditions.7PubMed Central. Let-7 derived from endometrial extracellular vesicles is an important inducer of embryonic diapause in mice The takeaway is that the uterine environment is not merely a passive container. The surrogate’s endometrium is an active participant in the earliest stages of embryonic development, delivering molecular signals that shape how the embryo’s own genes are expressed.
These microRNAs are not DNA in the traditional sense of contributing to the child’s genome. They are regulatory molecules. But they originate from the surrogate’s body and directly modulate gene activity inside the embryo. The line between “passing on DNA” and “not passing on DNA” gets philosophically blurry here: the surrogate’s genetic material is being transcribed in her cells, packaged into vesicles, absorbed by the embryo, and used to regulate the embryo’s gene expression. Her genome is participating in the process, even though her chromosomes are not part of the child.
The Egg Donor’s Molecular Legacy
While the surrogate’s uterus influences the embryo after transfer, the egg donor contributes something beyond just chromosomal DNA. The egg cell (oocyte) comes loaded with proteins and messenger RNA molecules that were produced during the egg’s development and stored in its cytoplasm. These molecules, products of what are called maternal effect genes, guide the very first steps of embryonic development before the embryo’s own genome kicks in.
Studies in mice have identified specific maternal effect genes like Nlrp2, whose protein products are built up during egg development and persist through to the blastocyst stage. When Nlrp2 is knocked out in oocytes, female mice become subfertile, demonstrating how critical these stored egg proteins are to early embryogenesis.8PLOS ONE. Nlrp2, a Maternal Effect Gene Required for Early Embryonic Development in the Mouse Similarly, research on the maternal effect genes UTX and JMJD3 showed that their transcripts are abundant in mature oocytes and begin to degrade after the embryo activates, becoming nearly undetectable by the blastocyst stage.9Scientific Reports. The Maternal Effect Genes UTX and JMJD3 Play Contrasting Roles in Mus musculus Preimplantation Embryo Development These genes do their work in a narrow window, bridging the gap between fertilization and when the embryo starts running its own genetic programs.
In gestational surrogacy using a donor egg, the egg donor rather than the surrogate provides all of this cytoplasmic machinery. The earliest hours and days of the embryo’s life are governed by molecules the egg donor’s body produced, even beyond the chromosomal DNA she contributed. The surrogate’s influence, through her uterine environment, comes later, once implantation begins and the placental connection is established.
Immune Tolerance and Why the Surrogate’s Body Doesn’t Reject the Embryo
In gestational surrogacy, the embryo is genetically foreign to the surrogate in every respect: it shares none of her nuclear DNA. You might expect the surrogate’s immune system to attack it the way it would attack a transplanted organ. The reason this doesn’t happen reveals another layer of biological interaction between the surrogate and fetus.
The placenta produces a molecule called HLA-G that acts as a kind of immune ceasefire signal. HLA-G binds to inhibitory receptors on the surrogate’s immune cells, particularly T cells and natural killer cells at the maternal-fetal interface. When these receptors engage HLA-G, the cells receive a signal to stand down rather than attack. Macrophages and dendritic cells also carry receptors for HLA-G, further dampening the immune response.10Frontiers in Immunology. HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
This system works whether the pregnancy is a natural conception, an IVF pregnancy, or a gestational surrogacy. The embryo’s trophoblast cells produce HLA-G regardless of the genetic relationship between the carrying mother and the fetus. It’s an elegant evolutionary solution to the problem of growing a genetically distinct organism inside another organism’s body. In surrogacy, the genetic mismatch is complete rather than partial, yet the immune tolerance system functions all the same.
What This Means for Prenatal Testing
The biological relationship between surrogate and fetus has practical implications for prenatal screening. During pregnancy, fragments of placental DNA circulate in the surrogate’s blood. This cell-free placental DNA provides a window into the fetal genome and is the basis for noninvasive prenatal testing, which screens for chromosomal abnormalities like Down syndrome from a simple blood draw.
In a typical pregnancy, the circulating DNA in the mother’s blood is a mixture of her own DNA and placental DNA. Because the placenta is genetically identical to the fetus in most cases, the test works by distinguishing fetal sequences from maternal ones. In gestational surrogacy, the situation is different: the surrogate’s DNA and the fetal DNA are entirely unrelated, which can actually make certain analytical steps easier. However, the basic biology of how cell-free placental DNA is released and cleared is still not fully understood, which limits the precision of these tests in any pregnancy.11PubMed Central. Cell-free placental DNA: What do we really know?
There is also the mitochondrial DNA question. In gestational surrogacy with a donor egg, the fetal mitochondrial DNA comes from the egg donor, not the surrogate. Research has confirmed that when surrogate pregnancies are analyzed, fetal-specific mitochondrial DNA variants in the surrogate’s blood plasma match the oocyte donor, reflecting the maternal inheritance pattern of mitochondria.12PubMed Central. Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: Detection and topology Clinicians working with surrogate pregnancies need to account for these differences when interpreting test results, particularly because some standard reference ranges assume a genetic relationship between the pregnant person and the fetus.
Legal and Identity Questions That Follow the Biology
The discovery that microchimerism is ubiquitous in human pregnancy has created quiet ripples in legal and ethical discussions. If a gestational surrogate’s cells can be found in the child’s body years after birth, and if her uterine environment shaped how the child’s genes are expressed, the clean legal distinction between “genetic parent” and “carrier” becomes messier than it first appears. Legal scholars have noted that conventional biomedicine and related law have been slow to acknowledge microchimerism, even as the evidence grows that genetically diverse cells within a single body are normal rather than exceptional.13Science, Technology, & Human Values. Maternal–Fetal Microchimerism and Genetic Origins: Some Socio-legal Implications
None of this changes the fundamental genetic reality: a gestational surrogate’s chromosomes are not in the child’s genome, and a standard DNA test will confirm parentage from the egg and sperm providers. But the biology does challenge the popular framing of surrogacy as a process in which the surrogate is merely an incubator with no biological connection to the child. The connection is real, just operating at a level that genetics textbooks traditionally ignored.
What Intended Parents and Surrogates Should Keep in Mind
For intended parents, the practical bottom line is reassuring: the child’s genetic identity belongs to the egg and sperm providers, full stop. A paternity or maternity DNA test will show no genetic match to the surrogate. The child will not inherit the surrogate’s eye color, blood type, or predispositions encoded in her chromosomes.
But the surrogate’s health during pregnancy genuinely matters for outcomes beyond genetics. Her nutrition, stress exposure, blood sugar levels, and overall health create the chemical environment in which the baby’s epigenome is set. This is not unique to surrogacy; it’s true of every pregnancy. What it means practically is that the care and wellbeing of the surrogate has lasting biological consequences for the child, reinforcing what good surrogacy programs already emphasize about prenatal health support.
For surrogates, knowing about microchimerism can be both validating and complicated. A few of the baby’s cells may circulate in her body long after delivery, just as some of her cells may persist in the child. This is not pathological. In most cases, microchimeric cells appear to integrate without causing problems, and some research suggests they may even play beneficial roles in tissue repair. The emotional weight of this biological exchange is personal and varies widely, but it is grounded in real physiology, not sentiment.
Mitochondrial DNA and the Three-Person Confusion
A question that occasionally surfaces in discussions about surrogacy is whether the surrogate contributes mitochondrial DNA to the baby. She does not. Mitochondria, the energy-producing structures in every cell, carry their own small genome and are inherited exclusively through the egg. In gestational surrogacy, the egg comes from the intended mother or a donor, so the mitochondrial DNA comes from that person, not the surrogate. Research on surrogate pregnancies has directly demonstrated this, showing that fetal mitochondrial DNA variants detected in the surrogate’s blood plasma match the oocyte donor rather than the surrogate herself.12PubMed Central. Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: Detection and topology
The confusion sometimes arises because of media coverage of mitochondrial replacement therapy, a separate technique in which a donor provides healthy mitochondria to replace faulty ones in an intended mother’s egg. That procedure does result in a child with DNA from three people: nuclear DNA from two parents and mitochondrial DNA from a donor. But this has nothing to do with surrogacy. A gestational surrogate’s mitochondria stay in her own cells. They do not migrate into the embryo or contribute to the child’s mitochondrial genome. The placenta allows nutrients, gases, waste products, hormones, and a small number of whole cells to cross between mother and fetus, but it does not swap out the embryo’s mitochondria.